𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Abnormalities of glutathione peroxidase and glutathione reductase in four patients with friedreich's disease

✍ Scribed by Wendell Helveston; Russell Hurd; Basim Uthman; B. J. Wilder

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
244 KB
Volume
11
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Micromethods in single muscle fibers: 2.
Micromethods in single muscle fibers: 2. Determination of glutathione reductase and glutathione peroxidase
✍ Lawrence Austin; Helen Arthur; Michael de Niese; Asitha Gurusinghe; Mark S. Bake πŸ“‚ Article πŸ“… 1988 πŸ› Elsevier Science 🌐 English βš– 441 KB

This paper extends the previous study for systems which control intracellular oxidative events in muscle and describes procedures suitable to assay glutathione peroxidase (GSHPx), glutathione reductase (GR), and total glutathione (GSH + GSSG) after fiber typing of individual muscle fibers. In human

Assessment of glutathione-S-transferase
Assessment of glutathione-S-transferase and glutathione reductase in patients with squamous-cell carcinoma of buccal mucosa
✍ Rakesh M. Rawal; Devendra D. Patel; Beena P. Patel; Mintoo M. Patel; Manish K. W πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 116 KB πŸ‘ 2 views

Serum and tumor cytosolic levels of glutathione-S-transferase (GST) and glutathione-reductase (GR) activity were determined spectrophotometrically. The levels were correlated with clinicopathological criteria and a tobacco-associated protein band (T band) found in serum. The results showed significa

Glutathione-S-transferase-1 and interleu
Glutathione-S-transferase-1 and interleukin-1Ξ² gene polymorphisms in Japanese patients with Parkinson's disease
✍ Masataka Nishimura; Sadako Kuno; Ryuji Kaji; Katsuhito Yasuno; Hideshi Kawakami πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 50 KB

## Abstract We studied genetic polymorphisms in the glutathione‐__S__‐transferase‐1 (GST‐1) gene region and the interleukin‐1Ξ² (IL‐1Ξ²) promoter region in patients with Parkinson's disease (PD, n = 361), as well as controls (n = 257). Although we have confirmed the previous results, in a larger samp